Sentec

The National Institute on Drug Abuse, part of the Department of Health and Human Services' National Institutes of Health, has issued a Notice of Intent to Sole Source for the procurement of Sentec V-Sign Sensors and ancillary supplies. This special notice announces the agency's intention to negotiate a sole source contract with Sentec Inc. for state-of-the-art digital monitoring equipment designed for noninvasive, continuous monitoring of transcutaneous carbon dioxide tension, pulse oximetry, pulse rate, and relative heating power. The equipment is intended for use across various clinical settings including neonatal and pediatric intensive care units, sleep laboratories, and post-operative care environments. The procurement falls under NAICS code 339112 for Surgical and Medical Instrument Manufacturing and is designated as an 8(a) sole source opportunity. The contract period is planned for one year, from September 30, 2025, to September 29, 2026.

The sole source determination is justified by Sentec's proprietary all-digital technology and unique sensor design, which the government considers the only solution safe for extended patient skin contact during sleep monitoring applications. Interested parties may submit capability statements to demonstrate their ability to provide equivalent products or services, with submissions due by September 18, 2025, at 12:00 PM EST. All capability statements must be submitted electronically to the designated contract specialist Joe Kennedy. The procurement is structured as a small business set-aside under the 8(a) program, indicating eligibility is restricted to certified small disadvantaged businesses participating in the SBA's 8(a) Business Development Program. Companies responding must demonstrate they can provide medical monitoring equipment that meets the specific technical requirements for noninvasive patient monitoring across multiple age groups and clinical environments.